We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

225 hedge funds and large institutions have $1.86B invested in Dynavax Technologies in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 85 increasing their positions, 65 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

515% more call options, than puts

Call options by funds: $13.4M | Put options by funds: $2.18M

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

31% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 65

13% more capital invested

Capital invested by funds: $1.64B → $1.86B (+$219M)

5% more funds holding

Funds holding: 215225 (+10)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

1.12% less ownership

Funds ownership: 98.95%97.84% (-1.1%)

Holders
225
Holders Change
+10
Holders Change %
+4.65%
% of All Funds
3.57%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
33
Increased
85
Reduced
65
Closed
20
Calls
$13.4M
Puts
$2.18M
Net Calls
+$11.2M
Net Calls Change
+$7.26M
Name Holding Trade Value Shares
Change
Change in
Stake
DT
151
Diversified Trust
Tennessee
$396K +$378K +26,842 New
Fidelity Investments
152
Fidelity Investments
Massachusetts
$394K +$53.1K +3,778 +16%
Handelsbanken Fonder
153
Handelsbanken Fonder
Sweden
$390K
AA
154
ALPS Advisors
Colorado
$370K +$352K +25,020 New
EFM
155
E Fund Management
China
$362K +$21.4K +1,525 +7%
HW
156
Hancock Whitney
Mississippi
$342K -$10.3K -730 -3%
IAM
157
Innovis Asset Management
Illinois
$334K +$102K +7,253 +47%
MOACM
158
Mutual of America Capital Management
New York
$333K -$10.8K -767 -3%
GS
159
GTS Securities
New York
$320K +$113K +8,053 +59%
Public Employees Retirement Association of Colorado
160
Public Employees Retirement Association of Colorado
Colorado
$318K -$689 -49 -0.2%
ZCM
161
Ziegler Capital Management
Illinois
$317K +$302K +21,452 New
WMSA
162
Weiss Multi-Strategy Advisers
New York
$310K +$29.4K +2,089 +11%
ProShare Advisors
163
ProShare Advisors
Maryland
$291K -$3.84K -273 -1%
OSAM
164
O'Shaughnessy Asset Management
Connecticut
$280K +$267K +18,991 New
Natixis Advisors
165
Natixis Advisors
Massachusetts
$255K +$243K +17,254 New
ATC
166
Argent Trust Co
Tennessee
$237K
Amundi
167
Amundi
France
$232K +$16.8K +1,198 +8%
WS
168
Wedbush Securities
California
$229K
NC
169
NinePointTwo Capital
California
$224K
Pictet Asset Management
170
Pictet Asset Management
Switzerland
$201K +$192K +13,616 New
HHGC
171
Hunting Hill Global Capital
New York
$198K -$14.1K -1,000 -7%
AIP
172
Ameritas Investment Partners
Nebraska
$190K +$30.6K +2,175 +20%
Capstone Investment Advisors
173
Capstone Investment Advisors
New York
$185K +$176K +12,542 New
Jane Street
174
Jane Street
New York
$177K -$1.88M -133,879 -92%
CIP
175
Cornerstone Investment Partners
Georgia
$166K +$159K +11,270 New

DVAX Hedge Fund Activity: Q3 2023 in Review

225 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2023, worth a combined $1.86B — up 13% from $1.64B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new DVAX positions and 20 closed out — a net gain of 13 holders — while 85 added to existing stakes and 65 trimmed.

The largest buyer was BlackRock, adding an estimated $29M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $34.9M sold.

  • 225 institutional investors held Dynavax Technologies (DVAX) as of Q3 2023, up from 215 in Q2 2023.
  • Funds reported $1.86B of Dynavax Technologies stock for Q3 2023, up 13% quarter-over-quarter.
  • 33 funds opened new Dynavax Technologies positions in Q3 2023 and 20 closed out, a net change of +13 holders.
  • The largest Dynavax Technologies buyer in Q3 2023 was BlackRock, an estimated $29M added.
  • The largest Dynavax Technologies seller in Q3 2023 was PFM Health Sciences, an estimated $34.9M sold.

Based on aggregated 13F filings for Q3 2023.